Page last updated: 2024-08-23

bezafibrate and Rhabdomyolysis

bezafibrate has been researched along with Rhabdomyolysis in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19904 (16.00)18.7374
1990's10 (40.00)18.2507
2000's8 (32.00)29.6817
2010's2 (8.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Hoshida, T; Kimura, A; Maeda, A; Mastuda, T; Nishida, S; Takeda, T; Tanabe, K; Tsubaki, M; Yanae, M1
Andresen, BS; Bastin, J; Benoist, JF; Boutron, A; de Lonlay, P; Djouadi, F; Ferdinandusse, S; Fukao, T; Habarou, F; Le Bachelier, C; Olpin, S; Schlemmer, D; Strauss, AW; Visser, G; Wanders, RJ; Yamaguchi, S1
Bastin, J; Behin, A; Bonnefont, JP; Djouadi, F1
Aubey, F; Bastin, J; Behin, A; Bonnefont, JP; Bresson, JL; Djouadi, F; Eymard, B; Gobin-Limballe, S; Laforêt, P; Mogenet, A; Ricquier, D; Romano, S; Vassault, A1
Matsuyama, K; Matzno, S; Mishima, M; Nakabayashi, T; Tanaka, H; Tazuya-Murayama, K; Uchida, T; Yasuda, S1
Fang, CC; Lee, YT; Su, TC; Yang, KC1
Fujioka, Y; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Sakoda, T; Tsujino, T; Tsutsumi, C; Yuba, M1
Bauer, K; Gabl, F; Haubenstock, A; Schmidt, P; Schröcksnadel, W1
Balcke, P; Haubenstock, A; Kopsa, H; Schmidt, P; Sertl, K; Zazgornik, J1
Arnold, R; Barth, M; Blech, M; Kaiser, H; Koop, I; Rumpf, KW; Scheler, F1
Bedani, PL; Gilli, P; Perini, L1
Fusegawa, H; Kawashima, N; Sato, F; Shindo, R1
Alcoy, E; García-Ramos, JL; Górriz, JL; Pallardó, LM; Sancho, A1
Cutrupi, S; Enia, G; Panuccio, V; Parlongo, S; Zoccali, C1
Michigishi, T; Takayama, T; Taki, J; Tonami, N; Tsuji, S1
Elisaf, MS; Milionis, HJ; Terrovitou, CT1
Madden, BP; Millner, R; Parker, J; Rolfe, LM; Seymour, CA; Sharobeem, KM1
Ben-Chetrit, S; Bernheim, J; Korzets, Z; Mor, A; Plotkin, E1
Kamaliah, MD; Sanjay, LD1
Muscari, A; Puddu, GM; Puddu, P1
Inoue, M; Jimi, T; Machida, H; Niwa, Y; Wakayama, Y1
Gas, JM; Perdiguero, M; Prados, MC; Rivera, F1
Autonell, J; Brugués, J; Kanterewicz, E; Riba, J; Sanmartí, R; Trias, I1
Cordi, GC; Corsi, L; Dapelo, M; De Micheli, A; Grimaldi, GP; Venzano, C1
Benker, G; Cissewski, K; Kienast, K; Reinwein, D; Windeck, R1

Reviews

2 review(s) available for bezafibrate and Rhabdomyolysis

ArticleYear
Lipid-lowering drugs: are adverse effects predictable and reversible?
    Cardiology, 2002, Volume: 97, Issue:3

    Topics: Aryl Hydrocarbon Hydroxylases; Bezafibrate; Cholesterol, LDL; Cytochrome P-450 Enzyme System; Digestive System; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver; Renal Insufficiency; Rhabdomyolysis; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases

2002
Bezafibrate induced rhabdomyolysis.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:4

    Topics: Aged; Bezafibrate; Female; Humans; Hypercholesterolemia; Hypertension; Indomethacin; Rhabdomyolysis

1992

Trials

1 trial(s) available for bezafibrate and Rhabdomyolysis

ArticleYear
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
    Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:1

    Topics: Activities of Daily Living; Acyl-CoA Dehydrogenase, Long-Chain; Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Exercise Test; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Humans; Hypolipidemic Agents; Lymphocytes; Male; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Muscular Diseases; Oxidation-Reduction; Oxygen Consumption; Pain; Palmitoyl Coenzyme A; Pilot Projects; Rhabdomyolysis; Treatment Outcome; Young Adult

2010

Other Studies

22 other study(ies) available for bezafibrate and Rhabdomyolysis

ArticleYear
Combination treatment with statins and bezafibrate induces myotoxicity via inhibition of geranylgeranyl pyrophosphate biosynthesis and Rho activation in L6 myoblasts and myotube cells.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022, Volume: 73, Issue:1

    Topics: Animals; Bezafibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Fibers, Skeletal; Myoblasts; Myotoxicity; Polyisoprenyl Phosphates; Rats; Rhabdomyolysis

2022
Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.
    Journal of inherited metabolic disease, 2016, Volume: 39, Issue:1

    Topics: Bezafibrate; Cardiomyopathies; Cell Line; Fibroblasts; Genotype; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Mitochondrial Trifunctional Protein, alpha Subunit; Mitochondrial Trifunctional Protein, beta Subunit; Mutation; Nervous System Diseases; Rhabdomyolysis

2016
Bezafibrate for an inborn mitochondrial beta-oxidation defect.
    The New England journal of medicine, 2009, Feb-19, Volume: 360, Issue:8

    Topics: Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Genes, Recessive; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Diseases; Oxidation-Reduction; Palmitoylcarnitine; Pilot Projects; Quality of Life; Rhabdomyolysis; RNA, Messenger; Statistics, Nonparametric

2009
Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:6

    Topics: Animals; Apoptosis; Bezafibrate; Cells, Cultured; DNA Fragmentation; Drug Synergism; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Myoblasts; Rats; Rhabdomyolysis; Structure-Activity Relationship

2003
Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:3

    Topics: Bezafibrate; Combined Modality Therapy; Female; Glomerulonephritis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Plasma Exchange; Renal Dialysis; Rhabdomyolysis

2005
Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
    The American journal of the medical sciences, 2005, Volume: 329, Issue:4

    Topics: Arthritis, Rheumatoid; Bezafibrate; Drug Interactions; Female; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Middle Aged; Rhabdomyolysis; Ribonucleosides

2005
Predominance of lactate dehydrogenase isoenzyme 1 in a patient with bezafibrate-induced rhabdomyolysis.
    Clinical chemistry, 1984, Volume: 30, Issue:9

    Topics: Adult; Bezafibrate; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Rhabdomyolysis

1984
[Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
    Deutsche medizinische Wochenschrift (1946), 1984, Jan-27, Volume: 109, Issue:4

    Topics: Adult; Bezafibrate; Humans; Kidney; Kidney Failure, Chronic; Male; Rhabdomyolysis

1984
[Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
    Klinische Wochenschrift, 1984, Apr-16, Volume: 62, Issue:8

    Topics: Aged; Bezafibrate; Creatine Kinase; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myoglobin; Myoglobinuria; Rhabdomyolysis

1984
Acute rhabdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis.
    Nephron, 1994, Volume: 68, Issue:4

    Topics: Acute Disease; Bezafibrate; Drug Overdose; Hemoglobins; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Rhabdomyolysis

1994
[Case of secondary carnitine deficiency (in a patient undergoing hemodialysis), developing rhabdomyolysis due to dehydration and the action of a hypolipemic agent].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Dec-10, Volume: 82, Issue:12

    Topics: Adult; Bezafibrate; Carnitine; Dehydration; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Rhabdomyolysis

1993
Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:12

    Topics: Acute Kidney Injury; Aged; Bezafibrate; Humans; Hypolipidemic Agents; Male; Rhabdomyolysis

1995
Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
    Nephron, 1996, Volume: 73, Issue:4

    Topics: Bezafibrate; Delayed-Action Preparations; Female; Humans; Hypolipidemic Agents; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Polycystic Kidney Diseases; Rhabdomyolysis

1996
Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Clinical nuclear medicine, 1996, Volume: 21, Issue:12

    Topics: Bezafibrate; Bone and Bones; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Muscle, Skeletal; Radionuclide Imaging; Rhabdomyolysis

1996
Acute rhabdomyolysis after bezafibrate re-exposure.
    Nephron, 1998, Volume: 78, Issue:3

    Topics: Aged; Bezafibrate; Female; Humans; Hypolipidemic Agents; Rhabdomyolysis

1998
Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group.
    Journal of cardiovascular pharmacology and therapeutics, 2000, Volume: 5, Issue:1

    Topics: Acute Kidney Injury; Aged; Anticholesteremic Agents; Bezafibrate; Cardiopulmonary Bypass; Clofibric Acid; Female; Fibric Acids; Humans; Male; Middle Aged; Rhabdomyolysis

2000
Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:5

    Topics: Acute Kidney Injury; Aged; Bezafibrate; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Influenza Vaccines; Male; Pyridines; Rhabdomyolysis

2000
Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
    Singapore medical journal, 2001, Volume: 42, Issue:8

    Topics: Acute Kidney Injury; Aged; Bezafibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases; Male; Rhabdomyolysis

2001
[Bezafibrate myopathy in two patients with chronic renal failure].
    Rinsho shinkeigaku = Clinical neurology, 1992, Volume: 32, Issue:7

    Topics: Aged; Bezafibrate; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Molecular Weight; Rhabdomyolysis

1992
[Rhabdomyolysis due to bezafibrate: a new case].
    Medicina clinica, 1992, Feb-01, Volume: 98, Issue:4

    Topics: Bezafibrate; Female; Humans; Middle Aged; Rhabdomyolysis

1992
[A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
    Minerva medica, 1990, Volume: 81, Issue:12

    Topics: Acute Disease; Acute Kidney Injury; Aged; Bezafibrate; Female; Furosemide; Humans; Rhabdomyolysis

1990
[Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
    Medizinische Klinik (Munich, Germany : 1983), 1988, Mar-04, Volume: 83, Issue:5

    Topics: Acute Kidney Injury; Bezafibrate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis

1988